Dose accuracy and durability of the NovoPen® 4 insulin delivery device before and after simulation of 5 years of use and under various stress conditions

Clinical Therapeutics

Volumn 31, Issue 12, 2009, Pages 2819-2823

  Kristensen, Carsten M ^a   Donsmark, Morten ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

diabetes; dose accuracy; insulin administration device; NovoPen 4

Indexed keywords

INSULIN;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENVIRONMENTAL TEMPERATURE; HUMIDITY; MECHANICAL STRESS; SIMULATION; TEMPERATURE STRESS;

DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; EQUIPMENT FAILURE; EQUIPMENT FAILURE ANALYSIS; EQUIPMENT REUSE; HUMIDITY; HYPOGLYCEMIC AGENTS; INJECTIONS; INSULIN; MATERIALS TESTING; REPRODUCIBILITY OF RESULTS; STRESS, MECHANICAL; TEMPERATURE; TIME FACTORS;

EID: 74549221015     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.12.005     Document Type: Article

References (16)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 329 (1993) 977-986
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [published correction appears in Lancet. 1999;354:602]. Lancet. 352 (1998) 837-853
3. Ohkubo Y., Kishikawa H., Araki E., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulindependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract. 28 (1995) 103-117
4. Shichiri M., Kishikawa H., Ohkubo Y., and Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 23 Suppl 2 (2000) B21-B29
5. Korytkowski M., Niskanen L., and Asakura T. FlexPen: Addressing issues of confidence and convenience in insulin delivery. Clin Ther. 27 Suppl B (2005) S89-S100
6. Kadiri A., Chraibi A., Marouan F., et al. Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Res Clin Pract. 41 (1998) 15-23
7. Lee W.C., Balu S., Cobden D., et al. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data [published correction appears in Clin Ther. 2006;28:1968-1969]. Clin Ther. 28 (2006) 1712-1725
8. Asakura T. Comparison of the dosing accuracy of two insulin injection devices. J Clin Res. 8 (2005) 33-40
9. Asakura T., Seino H., Kageyama M., and Yohkoh N. Dosing accuracy of two insulin pre-filled pens. Curr Med Res Opin. 24 (2008) 1429-1434
10. Hanel H., Weise A., Sun W., et al. Differences in the dose accuracy of insulin pens. J Diabetes Sci Technol. 2 (2008) 478-481
11. Donsmark M., Herold L., and Kristensen C.M. A comparison of injection force and dosage scale size between NovoPen 3 and NovoPen 4. Diabetes Technol Ther. 11 (2009) 581-585
12. DS/EN ISO 11608-1. Pen-injectors for medical use-Part 1: Pen-injectors-requirements and test methods. Charlottenlund, Denmark: Dansk Standard (2001)
13. ® 4. http://www.novonordisk.com/diabetes/hcp/injectiondevices/novopen4/default.aspx Accessed November 11, 2009.
14. Santiago O.M., Khutoryansky N.M., Bilbo C.M., et al. Accuracy and precision of the NovoPen 3 insulin delivery device after mechanical and temperature stresses. Endocr Pract. 8 (2002) 351-355
15. Clarke A., and Dain M.P. Dose accuracy of a reusable insulin pen using a cartridge system with an integrated plunger mechanism. Expert Opin Drug Deliv. 3 (2006) 677-683
16. ® [in Hungarian]. Magy Belorv Arch. 61 (2008) 109-115